Mount Sinai's $1M XPRIZE Bet: Can the Immune System Be Reset to Fight Aging?
Mount Sinai secured $1M in XPRIZE Healthspan funding to run NYC-Vita, a trial combining lifestyle and medication to restore immune function decades lost to aging.
Blood Filtering Is the New Wellness Flex — And Viome Just Bought the Infrastructure
Viome's acquisition of Circulate Health pairs multi-omics biomarker testing with therapeutic plasma exchange. What this convergence means for longevity-focused consumers navigating an increasingly clinical wellness stack.
Immorta Bio's Combination Therapy Reports 70%+ Lifespan Extension in Animal Models
A peer-reviewed study combining senolytic immunotherapy with stem cell regeneration shows dramatic lifespan gains. What the animal data does and doesn't tell us.
Ossium Health: The Case for Rebuilding the Immune System From Scratch
PRESERVE I trial: all 4 patients achieved full donor chimerism and remained relapse-free at Day 180 using banked deceased-donor bone marrow. What this means for longevity.
Your Immune System Can Now Have a Digital Twin — Here's What That Means
A Zurich clinic and Barcelona AI firm just launched the first commercial immune digital twin platform. It's early-stage, but the model it represents is where preventive health is heading.
NLRP3: The Inflammasome Switch Linking Aging to Chronic Disease
NLRP3 links obesity, Alzheimer's, and aging through a single inflammasome. Suppressing it extended mouse lifespan 34%. Q2 2026 clinical trial data is due.